How Bacteria Evade the Immune System

Escherichia coli can quickly evolve to resist engulfment by macrophages, scientists have found.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISABEL GORDOBacteria exposed to antibiotics rapidly acquire mutations that allow them to develop resistance to the drugs, and this process is fairly well understood. Scientists have now looked at the evolution of bacterial resistance toward live agents: cells of the immune system. In a report published in PLOS Pathogens today (December 12), a team led by Isabel Gordo from the Instituto Gulbenkian de Ciência in Oeiras, Portugal, challenged the common human intestinal bacterium Escherichia coli with mouse macrophages—immune system cells that engulf foreign elements like bacteria—and observed the rapid evolution of mutants capable of escaping capture. The same E. coli mutants could successfully establish infections in mice.

“This work on the development of E. coli macrophage resistance and virulence is important,” wrote James Shapiro, a professor of microbiology at the University of Chicago who was not involved in the work, in an e-mail to The Scientist. “It documents how encounters with mammalian host defense cells can stimulate rapid adaptation in bacteria.”

Although the authors only tested for E. coli virulence for one month, some mutants emerged in as few as four days.

Bacteria have evolved several defences to avoid being internalized by macrophages—sticky outer coverings, formation of filaments and biofilms among them. The evolution of such defences has been studied previously, but not through an evolutionary experiment such as this one performed by Gordo’s team. “I would have thought that the answer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Laasya Samhita

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours